Muhammad Mamdani
Muhammad Mamdani is a renowned pharmacologist and epidemiologist known for his significant contributions to the field of healthcare. He is currently the Vice President of Data Science and Advanced Analytics at Unity Health Toronto.
Early Life and Education[edit | edit source]
Muhammad Mamdani was born and raised in Canada. He completed his undergraduate studies in Pharmacy at the University of Toronto. He then pursued a Master's degree in Health Services Research from the same university. Mamdani furthered his education by obtaining a Doctor of Pharmacy degree from the University of Michigan and a Master's degree in Epidemiology from Harvard University.
Career[edit | edit source]
Mamdani has held several prestigious positions throughout his career. He served as the Director of the Applied Health Research Centre (AHRC) at the Li Ka Shing Knowledge Institute of St. Michael's Hospital. He also worked as a Senior Scientist in the Institute for Clinical Evaluative Sciences (ICES).
In his current role at Unity Health Toronto, Mamdani leads a team of data scientists and analysts to leverage data and advanced analytics to improve patient care and outcomes.
Research and Contributions[edit | edit source]
Mamdani's research primarily focuses on pharmacoeconomics, pharmacoepidemiology, and health services research. He has made significant contributions to the understanding of drug safety and effectiveness, healthcare system performance, and health policy.
His work has been widely recognized and cited in numerous peer-reviewed journals and he has received several awards for his contributions to healthcare research.
Awards and Recognition[edit | edit source]
Mamdani has been the recipient of several awards, including the Premier's Research Excellence Award from the Government of Ontario and the New Investigator Award from the Canadian Institutes of Health Research.
See Also[edit | edit source]
- Pharmacology
- Epidemiology
- Health Services Research
- Unity Health Toronto
- Li Ka Shing Knowledge Institute
- St. Michael's Hospital
- Institute for Clinical Evaluative Sciences
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
